Changed Profile of Serum Transferrin Isoforms in Primary Biliary Cholangitis.

capillary electrophoresis glycosylation primary biliary cholangitis transferrin isoforms

Journal

Journal of clinical medicine
ISSN: 2077-0383
Titre abrégé: J Clin Med
Pays: Switzerland
ID NLM: 101606588

Informations de publication

Date de publication:
08 Sep 2020
Historique:
received: 06 08 2020
revised: 19 08 2020
accepted: 01 09 2020
entrez: 11 9 2020
pubmed: 12 9 2020
medline: 12 9 2020
Statut: epublish

Résumé

Liver damage affects the synthesis of proteins and glycoproteins, and alters their posttranslational modification, such as glycosylation changing the serum profile of glycoprotein isoforms. The retention of hydrophobic bile acids in the course of cholestatic liver diseases is a major cause of liver damage in primary biliary cholangitis (PBC). The study objective was to determine the serum profile of transferrin isoforms in primary biliary cholangitis and compare it to transferrin isoforms profile in extrahepatic cholestasis. The study was carried out in 76 patients with PBC and 40 healthy blood donors. Transferrin isoforms were analyzed by the capillary electrophoresis method. The mean relative concentrations of disialotransferrin and trisialotransferrin in PBC were significantly lower than those in the healthy subjects (

Identifiants

pubmed: 32911601
pii: jcm9092894
doi: 10.3390/jcm9092894
pmc: PMC7564153
pii:
doi:

Types de publication

Journal Article

Langues

eng

Références

Ann Clin Lab Sci. 2016 May;46(3):286-90
pubmed: 27312554
J Hepatol. 1990 Sep;11(2):200-5
pubmed: 2254630
Annu Rev Biochem. 1985;54:631-64
pubmed: 3896128
J Hepatol. 1999 Mar;30(3):408-12
pubmed: 10190722
J Pediatr Gastroenterol Nutr. 2005 Aug;41(2):235-43
pubmed: 16056106
Biochem J. 1980 May 15;188(2):321-7
pubmed: 7396866
Ann Lab Med. 2019 May;39(3):291-298
pubmed: 30623621
Biochemistry. 1988 Nov 29;27(24):8787-94
pubmed: 3242608
Gut. 1990 Apr;31(4):431-4
pubmed: 2338269
Pediatr Res. 2001 Apr;49(4):519-31
pubmed: 11264436
Hepatology. 2009 Jul;50(1):291-308
pubmed: 19554543
Clin Rev Allergy Immunol. 2018 Apr;54(2):295-306
pubmed: 29181702
J Clin Invest. 1995 Mar;95(3):1253-61
pubmed: 7883974
J Immunol. 1987 May 15;138(10):3525-31
pubmed: 3571977
N Engl J Med. 1999 Feb 11;340(6):448-54
pubmed: 9971870
J Hepatol. 2017 Jul;67(1):145-172
pubmed: 28427765
J Clin Rheumatol. 2019 Jun;25(4):159-162
pubmed: 29782424
Clin Biochem. 2017 Dec;50(18):1131-1135
pubmed: 28673788
Clin Chim Acta. 1987 Jun 15;165(2-3):141-5
pubmed: 3652443
Clin Lab. 2017 Feb 1;63(2):349-354
pubmed: 28182352
Proc R Soc Med. 1967 Dec;60(12):1257-60
pubmed: 6066569
J Clin Invest. 1999 Jan;103(1):137-45
pubmed: 9884343
N Engl J Med. 2005 Sep 22;353(12):1261-73
pubmed: 16177252
Med Hypotheses. 1986 Jan;19(1):57-69
pubmed: 2871479
J Exp Med. 1993 Mar 1;177(3):657-66
pubmed: 7679706
Am J Surg Pathol. 1989;13 Suppl 1:43-9
pubmed: 2699167
Ann N Y Acad Sci. 1995 Jul 21;762:319-30
pubmed: 7545370

Auteurs

Agnieszka Grytczuk (A)

Department of Laboratory Diagnostics, University Clinical Hospital, 15-540 Bialystok, Poland.

Alicja Bauer (A)

Department of Biochemistry and Molecular Biology, Centre of Postgraduate Medical Education, 01-813 Warsaw, Poland.

Ewa Gruszewska (E)

Department of Biochemical Diagnostics, Medical University of Bialystok, 15-269 Bialystok, Poland.

Bogdan Cylwik (B)

Department of Pediatric Laboratory Diagnostics, Medical University of Bialystok, 15-274 Bialystok, Poland.

Lech Chrostek (L)

Department of Biochemical Diagnostics, Medical University of Bialystok, 15-269 Bialystok, Poland.

Classifications MeSH